Strategy: own the decision layer
PRISM’s own CPU/GPU engines remain the measured foundation. Proposed adapters would let qualified Gurobi, NVIDIA cuOpt and future QPUs serve selected workloads behind one client-facing decision service. Integrations, redistribution rights and per-model qualification must be established; the deck does not claim existing integrations or a cuOpt benchmark. The intended moat is permissioned workflow integration, client-rule history, auditable validation records, measured service reliability and reusable onboarding. These require adoption to become defensible assets.
Expansion gates: first win direct indexing and rebalancing at large US platforms; expand into wealth and asset management after repeatable deployments and renewals; enter energy or other deadline-driven domains after separate model and buyer validation; explore error-corrected quantum finance around 2030+ only if hardware availability and end-to-end economic benefit justify it. This fourth stage is not dependent on launching energy first. Avoid a fixed market-share or trillion-dollar valuation promise. At an illustrative 20× annual-revenue multiple, $1T equity value requires $50B annual revenue; even the $147T global-AUM ceiling at 1 bp yields only $14.7B hypothetical annual software revenue before market share and costs. A trillion-dollar outcome is therefore not justified by this financial-market model.
Quantum: explicit, conditional economics
Base quantum revenue and valuation premium: $0. Proposed optional software module: $25K per platform annually, excluding QPU usage and integration. Same 20 candidates × $25K = $500K maximum cohort option if all qualify, not an additional asset market or base SAM. One module at month 36 adds $25K to $750K base ARR = $775K; this is conditional on useful quantum hardware, measured economic advantage and a paying customer. No separately sized quantum TAM is claimed.
The $2M seed, $8M pre-money, 20% dilution and 24-month runway remain proposed terms. Faster benchmark results do not mechanically increase valuation. Within the existing $1M engineering allocation, earmark $100K for quantum research; within the existing $160K compute/data allocation, earmark $20K for quantum experiments. Thus quantum is $120K, or 6% of the raise, and the remaining $1.88M covers all other items including the $200K reserve. The total operating budget remains $1.8M, or $75K per month. No extra headcount or QPU-hardware purchase is assumed.
Refreshed public research · 17 September 2026
Gurobi: commercial quote-based licensing. NVIDIA cuOpt: open-source Apache 2.0 engine; infrastructure and enterprise support are separate. A GPU solver alone cannot justify premium platform pricing.
MOSEK: PTS-NODE $9,000 perpetual, $2,250 annual maintenance. IBM CPLEX: starts at $320 per authorized user per month; not a production platform quote.
Cerulli: $864.3B DI assets at year-end 2024, retained as historical context; the current model instead uses MMI–Cerulli Q1 2026 $1.2T. BCG: $147T global AUM at year-end 2025, an ecosystem ceiling. IBM roadmap: targets fault-tolerant hardware in 2029; it does not establish PRISM advantage, commercial availability on required terms, or a finance TAM.
What the pricing research supports
| Category / provider | Observed basis | Meaning for PRISM |
| MOSEK · PTS-NODE | $9,000 perpetual + optional $2,250 annual maintenance | Base solver on one machine. A $150K platform licence must earn its premium through integration and operational value. |
| IBM CPLEX | From $320 / user / month, development only; production quoted | $3,840 annualised developer price is not an enterprise deployment price. |
| Gurobi / FICO Xpress | Gurobi requests a quote. No standard Xpress production price disclosed on the reviewed page. | No invented list prices or asserted licence savings. |
| Vestmark / Smartleaf / MSCI Barra | Vestmark: account / asset-linked pricing in its commissioned study. Smartleaf: price undisclosed in reviewed material. No verified Barra rate card obtained. | Portfolio platforms are closer in workflow, broader in scope. Their prices do not establish PRISM willingness to pay. |
| Wealthfront S&P 500 Direct | 0.09% / year, or 9 bps, managed service | Context only. $1.5B at 9 bps = $1.35M management revenue; a $150K PRISM fee would consume 11.1% before other costs. This is not a partnership or a like-for-like price comparison. |
Proposed offer and economic test
$25K one-off, eight-week paid pilot. Annual licence = $100K platform + $5 × contracted active-account capacity. Reference: 10K accounts = $150K; 50K = $350K; 100K = $600K. One bounded equity workflow and an agreed solve cadence. Customer VPC compute, market data, third-party licences and implementation are separate. Support, account definition, burst volume and service levels must be scoped after the pilot; the benchmark is not a fleet-capacity guarantee.
At 10K accounts of an assumed $150K each, the eligible book is $1.5B. The proposed $150K licence is equivalent to 1 bp of that book. At a $1B book it is 1.5 bps. This is a normalisation, not AUM billing. Target a customer-validated annual operating benefit of at least $450K (3× the $150K fee), after incremental compute / integration costs; no saving or tax-alpha claim is established. If the customer only needs a faster generic solver, this premium may not be justified.
TAM / SAM / SOM: explicit scenarios
Direct-indexing TAM proxy: MMI–Cerulli’s $1.2T Q1 2026 manager-traded DI assets × assumed 1 bp = $120M annual software potential. At 0.5–2 bps: $60–240M. This is not measured software spending, measured software spending, or a company-wide global TAM. Pricing is account-based; the yield is a separate top-down cross-check. Its precision comes from arithmetic, not market certainty.
Initial candidate SAM: 23 Tier 1 spreadsheet records − 1 Envestnet/Tamarac duplicate − 2 input-provider records (MSCI/Axioma, FactSet) = 20 candidate organisations. 20 × assumed $150K average annual contract = $3M. This is a named target-cohort scenario, not an exhaustive or validated SAM; each organisation still needs technical, budget and procurement qualification. It is not a measured subset of Cerulli's asset pool.
36-month SOM: 5 contracts × $150K = $750K ARR, requiring 25% of the initial cohort to convert. Downside 3 = $450K; upside 8 = $1.2M. No pilot fees, implementation fees, asset pools or modules are added again. These are goals, not probability-weighted forecasts or pipeline commitments.
Seed: $2M for a 24-month operating plan
Proposed priced round: $8M pre-money + $2M new cash = $10M post-money; 20% new-money ownership before an option-pool top-up or convertibles. This is a negotiating scenario, not an appraisal. Carta reports roughly 19–20% early-stage dilution and a $24M Q4-2025 US seed median post-money; those samples are context, not a French / European comp or evidence that PRISM is worth a particular amount.
Engineering $1M: founder allowance $200K over 24 months, two engineers at $160K fully loaded / year each ($640K), $160K specialist / QA allowance. Deployment $400K: forward-deployment role $250K over 24 months, integrations $100K, travel / selling $50K. Compute & data $160K. Security, legal & operations $240K (security $100K, legal $60K, operating / accounting / insurance $80K). Reserve $200K. All are proposed USD costs, not actual compensation or vendor quotes.
Operating spend $1.8M / 24 = $75K average / month; $200K reserve is additional. No revenue, tax credits, current cash or cloud grants subsidise runway. With the reserve preserved, a 25% cost overrun reduces runway to 19.2 months. FX, payroll location and hiring dates require budget validation. Existing bootstrap documents excluded salaries and do not establish this funded-team runway.
Targets from funding close: month 6 — reproducible customer-workload validation and first paid pilots; month 12 — eight cumulative paid pilots and first production contract; month 24 — three annual production contracts ($450K ARR) plus referenceable operating evidence. Pilot receipts are nonrecurring and excluded from ARR. Month-36 SOM is a later goal and may require further financing.
Sources
- P1 · MOSEK commercial pricing ↗
Published USD prices, effective September 1, 2025. PTS-NODE base: $9,000 perpetual plus optional $2,250 annual maintenance. A solver licence, not a managed portfolio platform.
- P2 · IBM CPLEX pricing ↗
Developer subscription starts at $320 per authorised user per month; development only. Production deployment is quoted.
- P3 · Gurobi licensing ↗
Commercial pricing is requested by quote; workstation, server, cloud and container licensing. No public standard production price used.
- P4 · VestmarkONE economic-impact study ↗
Vendor-commissioned Forrester study describes account / asset-based pricing. Composite solution costs include implementation and change management; not treated as a software rate card.
- P5 · Smartleaf portfolio management ↗
Portfolio management and tax-customisation scope. No standard software price disclosed in the reviewed official materials.
- P6 · Wealthfront S&P 500 Direct ↗
Published 0.09% annual management fee (9 basis points). Managed investment service; contextual economics, not a like-for-like software competitor price.
- P7 · Cerulli direct-indexing assets ↗
April 10, 2025 release: $864.3B direct-indexing assets at year-end 2024. Historical asset base, not a current revenue forecast. The software yield is our assumption.
- P8 · Carta early-stage financing context ↗
March 5, 2026: Q4 2025 primary seed median post-money valuation $24M; seed / Series A dilution approximately 19–20%. US Carta sample, not a PRISM valuation or a local market comp.
- P9 · FICO Xpress licensing ↗
Commercial licensing available; no standard production dollar price disclosed on the reviewed official page.
- P10 · Internal target cohort and proposed model
PRISM_Target_Company_Pipeline_Tier_1_3.xlsx: 23 Tier 1 records. Combine Envestnet / Tamarac, exclude MSCI / Axioma and FactSet input-provider records: 20 candidate organisations. Fit, budget and procurement remain assumptions, not customer commitments.